Clinical Trial Update: A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease

View source ↗

Summary

A clinical trial evaluating adalimumab for acute Vogt-Koyanagi-Harada disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vogt-koyanagi-harada Disease

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Tianjin Medical University | Conditions: Vogt-Koyanagi-Harada Disease, Adalimumab | Status: RECRUITING